Month: October 2019

Lexington Biosciences Converts Amounts Owed to Unsecured Demand Loans

VANCOUVER, BRITISH COLUMBIA – October 4, 2019 – Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) announces that it has reached agreement with third parties as well as certain directors and officers (collectively the “lenders”) of the Company to convert previous advances and unpaid amounts for services received of $654,186, in aggregate, into unsecured

Read More



Newsletter Updates

If you haven’t already done so, signup here to receive future editions and the latest company news direct to your inbox.

Latest News